The buyer here trained at one of three research universities
Three major research universities sit inside one small triangle, feeding a dense cluster of research firms and life-sciences suppliers. The person reading your marketing is often a working scientist.
Benchmarks in this market
- Pipeline closed, technical B2B
- $12.4MPipeline closed, technical B2B
- Pipeline value, specification-led content
- +356%Pipeline value, specification-led content
- Target account engagement
- 39%Target account engagement
- Sales cycle length, ABM
- -31%Sales cycle length, ABM
Illustrative ranges for engagements of this type, not verified Raleigh-Durham-specific client data. Orientation, not a guarantee. Your starting point changes the range.
How we work here: Remotely from our San Francisco office, with ET coverage for calls and travel for kickoffs. We don't claim a Raleigh-Durham office we don't have.
Clients across every market
What's actually different about the Research Triangle
The Research Triangle's big story is its cluster of contract research organizations, or CROs. These companies run clinical trials and lab research for drug and biotech companies.
The cluster centers on Research Triangle Park and draws on Duke, UNC-Chapel Hill and NC State, which turn out a steady stream of life-sciences and technical talent.
That makes the buyer different from Boston's. Boston's cluster centers on hospitals and the biotech companies themselves. Here, the buyer is more often a supplier selling into those companies: a CRO's business development lead, a lab-equipment or clinical-software vendor, or a logistics firm moving temperature-sensitive shipments.
Your pitch has to hold up with people who have real science training, not just a purchasing checklist.
Research buyers check the science first
Marketing from a CRO or lab-services firm gets read by people with graduate-level science training. They'll spot a wrong methodology claim in one sentence. Content that's roughly right about the science gets dismissed here. It has to be exactly right.
Your talent pipeline is a selling point
Three major research universities producing a steady flow of PhDs and technical graduates is a lasting advantage for companies here. Most never mention it in their marketing, even though it's often the most convincing argument to a buyer choosing a vendor.
Use the regulatory terms
GLP, GCP, FDA submission paths and ethics board reviews aren't jargon to soften here. They're the words a technical buyer uses to judge whether you understand their world. Avoiding them makes you look inexperienced, not friendly.
Boston-level talent at lower cost
The Triangle is much cheaper to live and operate in than Boston's biotech corridor, with research talent of the same caliber. That's a real reason to build here, and most local companies undersell it.
What usually moves first in Raleigh-Durham.
Based on what tends to be the binding constraint for companies in this market. Your audit may point somewhere else. We go where the numbers say.
Industry playbooks relevant in Raleigh-Durham
Specific playbooks for Raleigh-Durham businesses
- SEO for Painting Contractors
- SEO for Healthcare & Medical
- Content for Healthcare & Medical
- Web Development for Healthcare & Medical
- Digital Marketing for Industrial & Manufacturing
- Content for Industrial & Manufacturing
- Web Development for Industrial & Manufacturing
- SEO for Industrial & Manufacturing
- Digital Marketing for Education & EdTech
- Content for Education & EdTech
- SEO for Education & EdTech
- Web Development for Education & EdTech
- Digital Marketing for Healthcare & Medical
The part clients actually remember.
Not the reports. The uncomfortable conversation that changed the trajectory.
We had the capacity and the certifications the whole time. We just never had anywhere for a brand doing research at 11pm to actually find any of it before deciding to call someone else instead.
We had the technical capability the whole time. What we didn't have was a way to show a property owner we understood their actual numbers before they ever got on a call with us.
We were running two different companies out of one website and wondering why neither side converted well. Splitting them was obvious in hindsight and something we'd never have done ourselves.
Raleigh-Durham questions, answered straight.
Yes. We use writers with life-sciences or clinical research backgrounds, interview your scientific team, and have your team check every method and regulatory claim before it's published. Getting GLP, GCP or a trial-phase detail wrong is worse than saying nothing with this buyer. They notice straight away.
Other markets we work in
Let's look at your numbers.
A free 30-minute teardown of your funnel, ads, and site, run against what actually works in the Research Triangle. You keep the findings either way.